Khallaf N, Assaad M T, Helmy M F, Mansour H, Isaac N, Fam S, Kamal H, Guirguis N I
Community Medicine and Public Health, ARI National Program, Child Survival Project.
J Egypt Public Health Assoc. 1995;70(1-2):197-212.
The Hemophilus influenzae blood culture and nasopharyngeal isolates, collected during a limited Surveillance of Antimicrobial Resistance in 1991-1993 from 1,635 Egyptian children under 5 years of age, presenting with pneumonia to Embaba and Abbassia Fever Hospitals, were serotyped. The 8 blood culture isolates confirmed H. influenzae to be responsible for 0.5% of the cases of pneumonia, versus 50 Streptococcus pneumoniae blood culture isolates from the same population that confirmed it responsible for 3.1% of the cases. The invasive Hemophilus strains were exclusively isolated from infants below 1 year, from one hospital (Embaba), on one winter season (January to March, 1992). On serotyping, 50% of the blood culture isolates were found to be non-b by latex agglutination. Some 297 nasopharyngeal isolates from cases of pneumonia were also serotyped and 45% were found to be non-b, thus confirming the invasive strains findings. Furthermore, the typing results from ARI-free controls nasopharyngeal isolates--though limited--were consistent with the findings and showed a 43% proportion of non-b. These findings put a question mark on the benefit of a large scale use of the available H. influenzae type b polysaccharide and conjugated vaccines in Egypt. But before interpreting out data in terms of vaccine needs, more specifically designed epidemiological studies need to be conducted to assess the role of H. influenzae as a pathogen in Egypt.
1991 - 1993年期间,在对埃及1635名5岁以下因肺炎前往恩巴巴和阿巴西亚发热医院就诊的儿童进行的抗菌药物耐药性有限监测中,收集了流感嗜血杆菌血培养物和鼻咽分离株,并进行了血清分型。8份血培养分离株证实流感嗜血杆菌导致了0.5%的肺炎病例,而同一人群中50份肺炎链球菌血培养分离株证实其导致了3.1%的病例。侵袭性流感嗜血杆菌菌株仅从一家医院(恩巴巴)1992年冬季(1月至3月)1岁以下的婴儿中分离得到。血清分型显示,通过乳胶凝集试验,50%的血培养分离株为非b型。对约297份肺炎病例的鼻咽分离株也进行了血清分型,发现45%为非b型,从而证实了侵袭性菌株的结果。此外,无急性呼吸道感染对照的鼻咽分离株的分型结果——尽管有限——与这些发现一致,显示非b型的比例为43%。这些发现对在埃及大规模使用现有的b型流感嗜血杆菌多糖疫苗和结合疫苗的益处提出了疑问。但在根据疫苗需求解读我们的数据之前,需要进行更具针对性设计的流行病学研究,以评估流感嗜血杆菌在埃及作为病原体的作用。